SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016013
Filing Date
2023-09-25
Accepted
2023-09-25 17:10:24
Documents
14
Period of Report
2023-09-19
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20230919x8k.htm   iXBRL 8-K 39622
2 EX-16.1 cydy-20230919xex16d1.htm EX-16.1 2663
  Complete submission text file 0001558370-23-016013.txt   243795

Data Files

Seq Description Document Type Size
3 EX-101.SCH cydy-20230919.xsd EX-101.SCH 3247
4 EX-101.LAB cydy-20230919_lab.xml EX-101.LAB 632
5 EX-101.PRE cydy-20230919_pre.xml EX-101.PRE 9552
8 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20230919x8k_htm.xml XML 4303
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 231276511
SIC: 2834 Pharmaceutical Preparations